AHA approves RAConciliation simply because RACTrac compatible product RAConciliation.

AHA approves RAConciliation simply because RACTrac compatible product RAConciliation, the RAC Tracking and Denials Management system, exclusively available through RACauditor.com together with H.I.M. ON Contact, has been accepted by the American Hospital Association as a RACTrac compatible product. The AHA’s RACTrac is certainly a web-centered data collection system which will allow AHA to get and report the impact of RAC activity on hospitals in the united states. RAConciliation is definitely a web-structured solution for use by hospitals, outpatient and physicians services to log, track, reconcile and record on all aspects of any RAC audit request..

Adding drug to presurgery chemotherapy improves results for females with triple-harmful breast cancer The I-SPY 2 trial, an innovative, multidrug, phase II breasts cancer trial, has yielded excellent results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to regular presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to outcomes from the I-SPY 2 trial presented here at the 2013 San Antonio Breasts Tumor Symposium, held Dec.